This review explains why depression often occurs alongside many other diseases, including ME/CFS, autoimmune conditions, heart disease, and neurodegenerative disorders. The common link appears to be activation of inflammatory and oxidative stress pathways in both the brain and body. These pathways may act like a 'warning system' that produces depression symptoms such as fatigue, anxiety, and physical discomfort when the body detects a threat.
Why It Matters
For ME/CFS patients and researchers, this framework is significant because it positions ME/CFS within a broader inflammatory disease spectrum and explains why depression is so common in ME/CFS. Understanding shared inflammatory mechanisms may identify novel treatment targets and validate the biological basis of both conditions rather than attributing them solely to psychiatric causes.
Observed Findings
Depression shows consistent comorbidity with multiple neuroinflammatory, autoimmune, and medical disorders including ME/CFS, cardiovascular disease, rheumatoid arthritis, and multiple sclerosis.
Microglial activation and peripheral IO&NS pathway activation are documented in depression and in the listed comorbid conditions.
Depression in medical disorders is associated with reduced quality of life and increased morbidity and mortality.
Concomitant depression correlates with increased inflammatory burden and disease progression in medical disorders.
Inferred Conclusions
Shared peripheral and/or central IO&NS pathways are proposed as the common pathophysiological mechanism underlying depression and its comorbidities.
IO&NS pathways function as a detection system signaling threats through melancholic, anxiety, and fatigue/somatic symptoms.
Depression should be conceptualized as part of the spectrum of inflammatory and degenerative disorders rather than a purely psychiatric condition.
Activation of these pathways may explain why depression contributes to worse outcomes in medical disease.
Remaining Questions
Which IO&NS markers are most predictive of depression symptom severity in ME/CFS patients specifically?
What This Study Does Not Prove
This review does not prove causation—it identifies correlations and shared biological pathways. It does not establish that IO&NS activation causes depression in ME/CFS specifically, nor does it demonstrate that treating these pathways will resolve depression or fatigue. The narrative review format means conclusions depend on the authors' selection and interpretation of existing studies.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →